Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandra, Egypt.
Department of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, Alexandra, Egypt.
PLoS One. 2018 Aug 15;13(8):e0202110. doi: 10.1371/journal.pone.0202110. eCollection 2018.
Tramadol is an analgesic used to treat moderate to severe pain caused by cancer, osteoarthritis, and other musculoskeletal diseases. Cytochrome P450 system metabolizes tramadol and induces oxidative stress in different organs. Therefore, the present study aims at investigating the changes in the activities and the protein expressions of CYPs isozymes (2E1, 3A4, 2B1/2), antioxidants status, free radicals levels after pretreatment of rats with Curcumin and/or Gallic as single- and/or repeated-doses before administration of tramadol. In repeated-dose treatments of rats with tramadol, the activities of cytochrome P450, cytochrome b5, and NADPH-cytochrome-c-reductase, and the antioxidant enzymes including glutathione reductase, glutathione peroxidase, glutathione S-transferase, catalase, superoxide dismutase, and levels of glutathione were inhibited in the liver and the kidney of rats. Interestingly, such changes caused by tramadol restored to their normal levels after pretreatment of rats with either Curcumin and/or Gallic acid. On the other hand, repeated-dose treatment of rats with tramadol increased the activities of both dimethylnitrosamine N-demethylase I (DMN-dI), and aryl hydrocarbon hydroxylase (AHH) compared to the control group. However, pretreatment of rats with Curcumin and/or Gallic acid prior to administration of tramadol restored the inhibited DMN-dI activity and its protein expression (CYP 2E1) to their normal levels. On the other hand, tramadol inhibited the activity of ethoxycoumarin O-deethylase (ECOD) and suppressed its protein marker expression (CYP2B1/2), whereas Curcumin, Gallic acid and/or their mixture restored such changes to their normal levels. In conclusion, Curcumin and/or Gallic acid alleviated the adverse effects caused by tramadol. In addition, patients should be advice to take Curcumin and/or Gallic acid prior to tramadol treatment to alleviate the hepatic and renal toxicities caused by tramadol.
曲马多是一种用于治疗癌症、骨关节炎和其他肌肉骨骼疾病引起的中度至重度疼痛的镇痛药。细胞色素 P450 系统代谢曲马多并在不同器官中诱导氧化应激。因此,本研究旨在研究在曲马多给药前用姜黄素和/或没食子酸进行单次和/或重复剂量预处理后,大鼠 CYP 同工酶(2E1、3A4、2B1/2)的活性和蛋白表达、抗氧化状态、自由基水平的变化。在曲马多的重复剂量治疗中,大鼠肝和肾中的细胞色素 P450、细胞色素 b5 和 NADPH-细胞色素 c 还原酶的活性以及包括谷胱甘肽还原酶、谷胱甘肽过氧化物酶、谷胱甘肽 S-转移酶、过氧化氢酶、超氧化物歧化酶和谷胱甘肽水平在内的抗氧化酶被抑制。有趣的是,在用姜黄素和/或没食子酸预处理大鼠后,曲马多引起的这些变化恢复到正常水平。另一方面,与对照组相比,重复剂量治疗的大鼠的二甲基亚硝胺 N-脱甲基酶 I(DMN-dI)和芳烃羟化酶(AHH)的活性增加。然而,在用曲马多给药前用姜黄素和/或没食子酸预处理大鼠可将抑制的 DMN-dI 活性及其蛋白表达(CYP2E1)恢复到正常水平。另一方面,曲马多抑制了乙氧基香豆素 O-去乙基酶(ECOD)的活性并抑制了其蛋白标志物表达(CYP2B1/2),而姜黄素、没食子酸和/或它们的混合物将这些变化恢复到正常水平。总之,姜黄素和/或没食子酸减轻了曲马多引起的不良反应。此外,建议患者在接受曲马多治疗前服用姜黄素和/或没食子酸,以减轻曲马多引起的肝肾功能毒性。